Stocks and Investing Stocks and Investing
Thu, November 11, 2021
Wed, November 10, 2021

Vamil Divan Maintained (BHVN) at Strong Buy with Decreased Target to $135 on, Nov 10th, 2021


Published on 2024-10-27 18:36:36 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Mizuho, Maintained "Biohaven Ltd." (BHVN) at Strong Buy with Decreased Target from $137 to $135 on, Nov 10th, 2021.

Vamil has made no other calls on BHVN in the last 4 months.



There are 7 other peers that have a rating on BHVN. Out of the 7 peers that are also analyzing BHVN, 2 agree with Vamil's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $145 on, Tuesday, October 19th, 2021
  • Esther Rajavelu of "UBS" Downgraded from Strong Buy to Hold and Increased Target to $109 on, Tuesday, August 10th, 2021


These are the ratings of the 5 analyists that currently disagree with Vamil


  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $170 on, Wednesday, October 6th, 2021
  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $160 on, Wednesday, October 6th, 2021
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $156 on, Tuesday, October 5th, 2021
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $165 on, Monday, September 13th, 2021
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $150 on, Tuesday, August 3rd, 2021
Contributing Sources